Redeye expects improved numbers in Q4 relative to soft Q2-Q3 due to seasonality and improved underlying cost control. Also, we are encouraged by the recent positive deal flow, with one having a slight positive impact on our forecasts for 2024 and beyond while the other strengthens Transtema’s EV-charging business.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases